| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 54.395 | 186.801 | 198.547 |
| Total Income - EUR | - | - | - | - | - | - | 9 | 94.506 | 203.941 | 211.384 |
| Total Expenses - EUR | - | - | - | - | - | - | 6.389 | 84.047 | 188.762 | 202.269 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -6.380 | 10.459 | 15.179 | 9.116 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -6.380 | 9.676 | 13.529 | 3.038 |
| Employees | - | - | - | - | - | - | 0 | 2 | 8 | 7 |
Check the financial reports for the company - Mednatural Supliment S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 1.371 | 49.392 | 101.568 | 109.128 |
| Current Assets | - | - | - | - | - | - | 7.233 | 41.290 | 76.082 | 51.748 |
| Inventories | - | - | - | - | - | - | 1.886 | 7.076 | 9.171 | 2.813 |
| Receivables | - | - | - | - | - | - | 5.072 | 33.237 | 40.390 | 39.187 |
| Cash | - | - | - | - | - | - | 275 | 978 | 26.521 | 9.747 |
| Shareholders Funds | - | - | - | - | - | - | -6.340 | 788 | 13.653 | 16.615 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 92.945 | 89.894 | 163.997 | 144.261 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9313 - 9313" | |||||||||
| CAEN Financial Year |
9313
|
|||||||||
Comments - Mednatural Supliment S.r.l.